Dr. Shirish A. Shah
Chief Scientific Officer, Development and Regulatory Affairs
EZRA Pharma, LLC
Dr. Shah, currently as Chief Scientific Officer at EZRA Pharma(US) earned BPharm-BUDCT(Mumbai), MS Pharmaceutics-Connecticut(US) and PhD-Iowa(US) and holds RAC of RAPS(US). He is featured in US-Marquis Who’sWho in America; World; Medicine and Healthcare and Science and Engineering also holds 15 US/EU Patents covering complex formulations/technologies.
Currently at EZRA (6-years), he held 40-years’ leadership positions in US at ICON, 3-divisions of TEVA, Perrigo, Allergan, CIBA and DuPont, encompassing NCEs; 505(b)(2) NDAs and ANDAs with credentials of successful development of over 150 Generic and NDA Products taking from concepts to commercialization. He filed several First-To-File (FTF) and Para-IV ANDAs and given depositions.